Creo Medical Group Plc (CREO) Ord GBP0.001
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
11.25p
11.50p
20.30p
£46.40 million
11.25p
11.00p
9.30p
n/a
0.00p (0.00%) Previous:
0.00p
680,328
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue (£m) | 4.00 | 4.00 |
| Profit before tax (£m) | (29.00) | (26.40) |
| Adjusted EPS (p): | (8.00) | (8.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Creo Medical's SpydrBlade Flex device receives US FDA clearance
11 June 2025 07:44
-
Creo Medical eyes transition to full commercialisation in FY25
17 February 2025 08:00
-
Director dealings: Creo Medical chairman raises stake
16 December 2024 15:27
-
Notice of Capital Markets Day
27 October 2025 07:00
-
Capital Markets Day update
7 October 2025 11:37
-
Unaudited results for the six months ended 30 June
22 September 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.